Highest-scoring questions on the site.
Numbers first: a GLP-1 receptor agonist · 40 °C · seven days. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is…
Numbers first: cagrilintide · 25 °C · twenty-eight days. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell…
Concretely: a 0.5 mL insulin syringe · 30 mg · 10 mg/mL. I want the working, not the result — I need to be able to redo it with different numbers. I care about the…
I have three data points across nine months, which I hope is enough to see a trend. I would like the arithmetic checked rather than the conclusion asserted. I have…
I have continuous temperature data for the period in question, which is unusual and I would like to use it. I would rather over-plan the first cycle and simplify…
The particulars: 95.2% · PeptideMeter · 98.8% · Janoshik. The comparison I want does not seem to exist anywhere in a form I can evaluate. I have read the arguments…
The specifics, since they change the answer: QYB · HJ · Sweden. I am trying to choose between two options that are usually discussed as though only one exists. I am…
Details up front: cagrilintide · liraglutide. I have used one of these for a while and I am considering switching, which requires a reason. What I care about is…
The specifics, since they change the answer: 50 mg · 2.5 mL · phosphate-buffered diluent · orforglipron. I am at the decision point and I would rather think it…
The case in front of me: survodutide · SUSTAIN-6. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a…
I have both a purity figure and a content figure, which is why the discrepancy is visible. I am at the decision point and I would rather think it through than…
What I have: an HPLC purity test · orforglipron. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell me…
The specifics, since they change the answer: STEP 5 · early satiety. I have the document in front of me and I can read the numbers. What I cannot do is interpret…
For reference: oral semaglutide · SURMOUNT-1. I understand the observation; what I do not understand is the mechanism behind it. I have read the two review articles…
The particulars: liraglutide · three weeks · 4 °C. I understand the observation; what I do not understand is the mechanism behind it. I have read the two review…
Setup, so nobody has to ask: LDL-C · eight weeks · ecnoglutide. I noticed this today and I have not touched anything since, in case the state is diagnostic. I have…
Details up front: 99.4% · Janoshik · 97.1% · Janoshik. I have used one of these for a while and I am considering switching, which requires a reason. What I care about…
The specifics, since they change the answer: 98.8% · PeptideMeter · 97.9%. An unexpected observation, and I would like a differential rather than reassurance. The…
The specifics, since they change the answer: STEP 8 · survodutide. I have the document in front of me and I can read the numbers. What I cannot do is interpret them.…
I have both a purity figure and a content figure, which is why the discrepancy is visible. I have the document in front of me and I can read the numbers. What I…
The case in front of me: ecnoglutide · SURMOUNT-OSA. I want to know whether this is a real physical effect or an artefact of how it is measured. What prompted the…
The case in front of me: 98.8% · oral semaglutide · QSC. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and I…
What I have: SURMOUNT-OSA · retatrutide. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to…
Details up front: 30 mg · 6.67 mg/mL. I can do the algebra. I am not confident about the conversion factors. If there is a standard way to lay this out, I would…